We are excited to connect with you as a leading global provider of in vivo intravital combined confocal and two-photon microscopy, as well as a service organization for intravital in vivo imaging.
With the highly anticipatedAdvanced Imaging Methods (AIM 2025)fast approaching, we are delighted to invite you to visit us at the Brower Center in Berkeley from January 21st to 23rd. Additionally, we will be hosting a talk on Tuesday, January 21st at 2:45 PM, and aposter session on Wednesday, Jan 22nd evening.
As the countdown to AIM 2025 begins, we look forward to engaging with you and sharing valuable insights. After the workshop, we will also be hosting an intravital imaging webinar, presented by IVIM’s CEO, Prof. Dr. Pilhan Kim, on February 4th at 2:00 PM Pacific Time. This webinar, organized by the University of California, Berkeley’s Cancer Research Laboratory-Molecular Imaging Center, is open to everyone.
Abstract Title: Real-Time Imaging of Immune Cell Response to Small Molecule Drug Injection in the Tumor Microenvironment of Live Mice
Session: Wednesday, January 22nd, 2025: 6:00-8:00 PM, Li Ka Shing Center for Biomedical and Health Sciences
Key Points:
Optimizing Small Molecule Drugs: Intravital microscopy (IVM) enables real-time observation of how small molecule drugs interact with immune cells within the tumor microenvironment, providing insights into optimizing drug dosing and timing to enhance immune responses in combination therapies.
Precision IVM Imaging for Immunotherapy: IVM allows for the direct visualization of drug-immune dynamics at a cellular level, offering the potential to refine immunotherapy approaches by identifying specific immune cell behaviors and drug effects in live tissue, leading to more tailored and effective cancer treatments.